Do you want to read an article? Please log in or register.
Endothelial-to-Mesenchymal Transition in Bone Marrow and Spleen of Primary Myelofibrosis
Related content
Leukemia
Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia
Lancet Oncol.
Wong JYC, Filippi AR, Scorsetti M, Hui S, Muren LP, Mancosu P
doi: 10.1016/S1470-
RECOMMENDED
Lymphoma
Primary bone lymphoma: Clinical presentation and therapeutic considerations
★ 2
Recommended by
Alexander Meisel, Faculty Member
J Bone Oncol.
Müller A, Dreyling M, Roeder F, Baur-Melnyk A, Knösel T, Klein A, Birkenmaier C, Jansson V, Dürr HR
doi: 10.1016/j.jbo.2020.100326.Visit the original publication at ncbi.nlm.nih.gov
Clinical significance of epithelial-to-mesenchymal transition in laryngeal carcinoma: its role in the different subsites
Head Neck.
Mezi S, Chiappetta C, Carletti R, Nardini A, Cortesi E, Orsi E, Piesco G, Di Gioia C
doi: 10.1002/hed.24838.
Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN
Ann Hematol.
Breccia M, Andriani A, Montanaro M, Abruzzese E, Buccisano F, Cedrone M, Centra A, Villivà N, Celesti F, Trawinska MM, Massaro F, Di Veroli A, Anaclerico B, Colafigli G, Molica M, Spadea A, Petriccione L, Cimino G, Latagliata R
doi: 10.1007/s00277-016-2884-7.
Further Publications
A patient with a germline GATA2 mutation and primary myelofibrosis
Blood Adv
Rütsche CV, Haralambieva E, Lysenko V, Balabanov S, Theocharides APA
doi: 10.1182/bloodadvances.2020003401
Leukemia
Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin
Haematologica.
Baron F, Galimard JE, Labopin M, Yakoub-Agha I, Niittyvuopio R, Kröger N, Griskevicius L, Wu D, Forcade E, Richard C, Aljurf M, Helbig G, Labussière-Wallet H, Mohty M, Nagler A
doi: 10.3324/haematol.2019.227603.
Lymphoma
Second primary malignancy in myelofibrosis patients treated with ruxolitinib
Br J Haematol.
Polverelli N, Elli EM, Abruzzese E, Palumbo GA, Benevolo G, Tiribelli M, Bonifacio M, Tieghi A, Caocci G, D'Adda M, Bergamaschi M, Binotto G, Heidel FH, Cavazzini F, Crugnola M, Pugliese N, Bosi C, Isidori A, Bartoletti D, Auteri G, Latagliata R, Gandolfi L, Martino B, Scaffidi L, Cattaneo D, D'Amore F, Trawinska MM, Stella R, Markovic U, Catani L, Pane F, Cuneo A, Krampera M, Semenzato G, Lemoli RM, Vianelli N, Breccia M, Russo D, Cavo M, Iurlo A, Palandri F
doi: 10.1111/bjh.17192.
Leukemia
Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort
Ann Hematol
Brune MM, Stüssi G, Lundberg P, Vela V, Heim D, Manz MG, Haralambieva E, Pabst T, Banz Y, Bargetzi M, Grobholz R, Fehr M, Cogliatti S, Ossenkoppele GJ, Löwenberg B, Rudolf CB, Li Q, Passweg J, Mazzuchelli L, Medinger M, Tzankov A, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK).
doi: 10.1007/s00277-021-04467-2
Multiple Myeloma (MM)
Imaging and Bone Marrow Assessments Improve Minimal Residual Disease Prediction in Multiple Myeloma
Am J Hematol.
Alonso R, Cedena MT, Gómez-Grande A, Ríos R, Moraleda JM, Cabañas V, Moreno MJ, López-Jiménez J, Martín F, Sanz A, Valeri A, Jiménez A, Sánchez R, Lahuerta JJ, Martínez-López J
doi: 10.1002/ajh.25507.